Abstract
Functional foods are defined as foods that have disease-preventing and/or health-promoting benefits in addition to their basic nutritive value (Southon, S. 2000. Factors to consider when undertaking clinical trials for functional foods. In Functional foods II, claims and evidence, ed. J. Buttriss and M. Saltmarsh, 3–8. Cambridge: The Royal Society of Chemistry). Marine-derived bioactive compounds fit convincingly within this definition and they may be used as functional food ingredients. For example, marine-derived dietary fibers including oligosaccharides such as fucoidan, can be viewed as functional food ingredients as they can impart health benefits to the consumer beyond those associated with basic nutrition. However, consumers require clarification regarding the concept of functional foods. It is now necessary, in Europe, to define the actual health benefit of a particular functional food due to regulations introduced by the European Union (that are discussed in this chapter) and the formation of the European Food Safety Authority (EFSA). Marketing of food ingredients as “bioactives with health benefits” now requires substantial scientific substantiation in Europe and it is now necessary to provide evidence of any benefit before any health claims can be made on a functional food product. The European Commission Concerted Action on Functional Food Science in Europe (FUFOSE), coordinated by the International Life Sciences Institute – ILSI Europe, was established in 1986 to establish a science-based approach for concepts in functional foods. The aims of FUFOSE were:
-
To assess critically the science base required to provide evidence that specific nutrients and food components positively affect target functions in the body
-
To examine the available science from a function-driven perspective rather than a product-driven one
-
To reach consensus on targeted modifications of food and food constituents, and options for their application (Diplock et al. 1999)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arai, S. 1996. Studies on functional foods in Japan-state of the art. Bioscience, Biotechnology, and Biochemistry 60: 9–15.
Arai, S., T. Osawa, H. Ohigashi, M. Yoshikawa, S. Kaminogawa, M. Watanabe, T. Ogawa, K. Okubo, S. Watanabe, H. Nishino, K. Shinohara, T. Esashi, T. Hirahara. 2001. A mainstay of functional food science in Japan – History, present status, and future outlook. Bioscience, Biotechnology, and Biochemistry 65(1): 1–13.
Asp, N.-G., and S. Bryngelsson. 2008. Health claims in Europe: new legislation and passclaim for substantiation. The Journal of Nutrition 138(6): 1210S–1215S.
Diplock, A.T., P.J. Aggett, M. Ashwell, F. Bornet, E.B. Fern, and M.B. Roberfroid. 1999. Scientific concepts of functional foods in Europe: consensus document. British Journal & Nutrition, 81 Supp. 1, S7–S27.
Diplock, A.T., P.J. Aggett, M. Ashwell, F. Bornet, E.B. Fern, and M.B. Roberfroid. 2000. Scientific concepts of functional foods in Europe: consensus document. In Functional foods II, ed. J. Buttriss and M. Saltmarsh, 8–59. Cambridge: The Royal Society of Chemistry.
Eberjard, J., and I. Zajac. 2010. Bringing functional foods to market: FDA’s regulatory mandate drives the process. Nerac White Paper, pp. 2–11.
Fujita, H. 2001. Human study of sardine peptide on blood pressure. Nutrition Research 21: 1149.
Hata, Y., M. Yamamoto, M. Ohni, K. Nakajima, Y. Nakamura, and T. Takamo. 1996. A placebo-controlled study of sour milk on blood pressure in hypertensive subjects. American Journal of Clinical Nutrition 64: 767–771.
McNamara, S.H., and S.H. McNamara. 1998. So you want to market a food and to make health-related claims – how far can you go? What rules of law will govern the claims you want to make? Food and Drug Law Journal 53: 421–434.
Ministry of Health. 1996. The regulation for health foods. Beijing: China Standards.
Morinaga, Y., T. Shimizu, K. Sueki, and T. Hirahara. 2000. Health claim on functional foods. Japan: International Life Scientific of Japan.
Sekiya, S., Y. Kobayashi, and E. Kita. 1992. Effect of hydrolyzed casein on hypertension and its adverse effect. Japanese Journal of Nutrition and Foods 45: 513–517.
Shimizu, T. 2003. Health claims on functional foods: the Japanese regulations and an international comparison. Nutrition Research Reviews 16: 241–252.
Shimizu, T., Y. Morinaga, T. Tokunaga, S. Seki, K. Sueki, and T. Hirahara. 2001. Functional food science in Japan, 2–13. Japan: International Life Scientific of Japan.
Southon, S. 2000. Factors to consider when undertaking clinical trials for functional foods. In Functional foods II, claims and evidence, ed. J. Buttriss and M. Saltmarsh, 3–8. Cambridge: The Royal Society of Chemistry.
State Food and Drug Administration. 2005. The guideline of registration for functional food. Beijing: China Standards. http://www.sfda.gov.cn/syjz0461/syjz0461.htm.
Yamatoya, K. 1995. Effects of hydrolysed guar gum on frequency and characteristics of evacuation. Journal of Japanese Society of Nutrition and Food Science 46: 199–203.
Yang, Y. 2008. Scientific substantiation of functional food health claims in China. The Journal of Nutrition Supplement: 1199S–1205S.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hayes, M. (2012). Marine-Derived Functional Foods: Claims and Current Legislation. In: Hayes, M. (eds) Marine Bioactive Compounds. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1247-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1247-2_8
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-1246-5
Online ISBN: 978-1-4614-1247-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)